TARS · Tarsus Pharmaceuticals, Inc. · Exempt Offerings
$78.20
-0.48 (-0.61%)
At close · Nov 17
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$3.86B
Shares
49.31M
Volume · Nov 17
542.25K
Avg daily vol (3M)
874.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.
Key facts
CIK
1819790
CUSIP
87650L103
13F (30d)
263 filings
247 filers
Visit website
Investor relations